Product Details
Additional Information
| Product Name | Humira 40 Mg/0.4 Ml Pen 2/Pac |
| Application | Tumor Necrosis Factor (TNF) Inhibitor |
| Generic Drug Name | Adalimumab |
| Mechanism of Action | Inhibits TNF-alpha, a cytokine involved in inflammation |
| Dosage Form | Subcutaneous Injection |
| Strength | 40 mg / 0.4 mL |
| Common Side Effects | Injection site reactions, headaches, upper respiratory tract infections |
| Storage Requirements | Store in the refrigerator at 2°C–8°C (36°F–46°F); do not freeze |
| Injection Instructions | Allow to reach room temperature before use, inject into the thigh or abdomen (except near navel or injection site scars) |
| Container Type | Pre-filled Pen |
| Quantity | 2 Pen |
| Indications | Treatment of rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis |
Description
Humira® (adalimumab) is a biologic medication used to treat a variety of inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, and plaque psoriasis. It is a tumor necrosis factor (TNF) inhibitor that works by targeting and inhibiting TNF-alpha, a protein involved in the inflammatory process. By blocking TNF-alpha, Humira® reduces inflammation and helps to alleviate symptoms associated with autoimmune diseases.
The medication is delivered via subcutaneous injection using the Humira® pen, containing a 40 mg/0.4 mL dosage. The pen is pre-filled and designed for self-administration by patients who have been instructed by their healthcare provider. Humira® is typically administered every two weeks for most conditions, although the dosing schedule may vary based on the disease being treated.
Common side effects of Humira® include injection site reactions, headaches, and upper respiratory tract infections. Serious side effects can include increased risk of infections, such as tuberculosis, fungal infections, and bacterial infections, as well as the potential for certain cancers.
Frequently Asked Questions (FAQs)
The cost of HUMIRA 40MG/0.4ML PEN 2/PAC is $available for registerd members only
HUMIRA 40MG/0.4ML PEN 2/PAC is manufactured by Abbvie.
You can purchase HUMIRA 40MG/0.4ML PEN 2/PAC on our website at https://preview_supplies.pipelinemedical.com/Products/Detail/humira-pen-kt-40mg-0-4ml-2-cit-f-650133
You might also like
Sterilization Wraps: CSR Quick Check Sterilization Wrap, 24" x 24"
Company name
|
PID: 1726364
|
MFG#: 47346389
|
NDC: 294475833
UOM:50/BX
+ 4 Variants
Sterilization Wraps: CSR Quick Check Sterilization Wrap, 24" x 24"
Company name
|
PID: 1726364
|
MFG#: 47346389
|
NDC: 294475833
UOM:50/BX
+ 4 VariantsSterilization Wraps: CSR Quick Check Sterilization Wrap, 24" x 24"
Company name
|
PID: 1726364
|
MFG#: 47346389
|
NDC: 294475833
UOM:50/BX
+ 4 VariantsSterilization Wraps: CSR Quick Check Sterilization Wrap, 24" x 24"
Company name
|
PID: 1726364
|
MFG#: 47346389
|
NDC: 294475833
UOM:50/BX
+ 4 VariantsSterilization Wraps: CSR Quick Check Sterilization Wrap, 24" x 24"
Company name
|
PID: 1726364
|
MFG#: 47346389
|
NDC: 294475833
UOM:50/BX
+ 4 VariantsSterilization Wraps: CSR Quick Check Sterilization Wrap, 24" x 24"
Company name
|
PID: 1726364
|
MFG#: 47346389
|
NDC: 294475833
UOM:50/BX
+ 4 Variants